- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
4 result(s) found for: Hamartoma.
Displaying page 1 of 1.
EudraCT Number: 2015-005416-15 | Sponsor Protocol Number: SIPA-SOS | Start Date*: 2016-10-20 |
Sponsor Name:Medical Center - University of Freiburg [...] | ||
Full Title: An open label phase II study of Sirolimus in patients with segmental overgrowth syndrome | ||
Medical condition: Segmental overgrowth syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024078-20 | Sponsor Protocol Number: RSW2011 | Start Date*: 2011-05-11 | |||||||||||
Sponsor Name:Instituto Científico y Tecnológico de Navarra | |||||||||||||
Full Title: Ensayo clínico fase II, aleatorizado, triple ciego, controlado intraindividualmente con placebo, para evaluar la eficacia y seguridad de la rapamicina tópica sola o asociada a láser de colorante pu... | |||||||||||||
Medical condition: Malformación capilar cutánea en pacientes con síndrome de Sturge-Weber. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022837-27 | Sponsor Protocol Number: CNTO328MCD2002 | Start Date*: 2012-12-17 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: An Open-label, Multicenter Study to Evaluate the Safety of Long-term Treatment with Siltuximab in Subjects with Multicentric Castleman's Disease | |||||||||||||
Medical condition: Multicentric Castleman's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012380-34 | Sponsor Protocol Number: CNTO328MCD2001 | Start Date*: 2010-05-18 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of CNTO 328 (Anti-IL-6 Monoclonal Antibody) Plus Best Supportive Care Compared With Best Supportive Care in Su... | |||||||||||||
Medical condition: Multicentric Castleman's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) ES (Completed) DE (Completed) FR (Completed) NL (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.